New research indicates that people who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise plans.
Research printed in a major health publication demonstrates that while overweight individuals can lose a large proportion of their total mass while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"Individuals purchasing these drugs need to be informed of the risk of rapid rebound weight gain when the treatment ends," stated lead investigator Dr. Susan Jebb.
That rate of regain suggests a return to original mass in about one and a half years.
Analyzing Approaches
The research, which reviewed dozens of trials involving thousands of patients, compared the effects of the injectable medications with older methods.
Scientists point out that individuals who shed pounds through diet and exercise typically see a less rapid creep back—around 100 grams monthly—post-intervention.
Understanding the Rapid Regain
Doctors propose the mechanism of the injections is key to understanding the amplified rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous hormone, and could lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication leads to appetite is no longer kept in check, making overeating far more likely."
A Lifelong Disease?
Health authorities advise the injections for people with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians contend that, given the likelihood of weight regain, the treatment might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who note that the findings "highlight the long-term character of obesity," akin to managing conditions like diabetes.
User Accounts
Users who have stopped the jabs report a powerful resurgence of appetite.
"I experienced a switch that goes on and you're instantly starving," said an individual.
This challenge is worsened if users have not established permanent lifestyle or habit modifications during therapy.
Growing Interest
Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with desire remaining high.
- Adoption is higher among women compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Ultimately, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a standalone solution and long-term success hinges on ongoing lifestyle management.
